Related references
Note: Only part of the references are listed.Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review
Hannah C. Timmins et al.
JOURNAL OF CANCER SURVIVORSHIP (2023)
Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas
Martina Catalano et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Risk factors for the development of paclitaxel-induced neuropathy in breast cancer patients
Jetter Robertson et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2018)
Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
Zohreh Ghoreishi et al.
BMC CANCER (2018)
Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics
Andreas A. Argyriou et al.
NATURE REVIEWS NEUROLOGY (2017)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy
FH Hausheer et al.
SEMINARS IN ONCOLOGY (2006)